Powered by

FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care

Dec 04, 2018 - PR Newswire

PR Newswire

The U.S. Food and Drug Administration today took a significant step forward in driving the efficient development of novel diagnostic technologies that scan a person's DNA to diagnose genetic diseases and guide medical treatments. For the first time, the agency has formally recognized a public database that contains information about genes, genetic variants and their relationship to disease. The FDA is recognizing the genetic variant information in the Clinical Genome Resource (...